Hope for stubborn skin rash: existing drug tested for Hard-to-Treat eczema
Disease control
Ongoing
This study is testing whether an existing medication called dupilumab (brand name Dupixent) can help people with nummular eczema, a chronic, itchy skin rash that is often difficult to treat. The trial will involve 70 adults with moderate-to-severe cases to see if the drug reduces…
Phase: PHASE2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC